Industry: Manufacturing (SIC 2834 — Pharmaceutical Preparations)
Of the 1,001 filings in this window, 18 (1.8%) are routine debt or shelf offerings (form 424B*, FWP, S-3*), which are excluded from the routine rate below because large issuers generate them continuously.
| Form type | Filings in window |
|---|---|
| 4 | 719 |
| 8-K | 59 |
| DEFA14A | 26 |
| SC 13G/A | 25 |
| SC 13D/A | 21 |
| 10-Q | 17 |
| 3 | 14 |
| 11-K | 13 |
| SC 13G | 12 |
| PX14A6G | 10 |
| 13F-HR | 7 |
| SCHEDULE 13G/A | 6 |
| DEF 14A | 6 |
| 10-K | 6 |
| Metric | Value |
|---|---|
| Window covered | 2021-02-17 → 2026-10-01 |
| Span | 5.62 years |
| All filings in window | 1,001 |
| Routine filings (offerings excluded) | 983 |
| Routine filings per year | 175 |
| Insider forms as share of routine filings | 73.2% |
| Routine debt/shelf offering share | 1.8% |
Former names on record: PFIZER INC
| Field | Value |
|---|---|
| CIK | 0000078003 |
| Tickers | PFE |
| Exchange | NYSE |
| State of incorporation | DE |
| Fiscal year end | 1231 |
| Filer category | Large accelerated filer |
Raw EDGAR source for this entity: submissions/CIK0000078003.json · EDGAR filings list